Advanced search
Publication Cover
Current Medical Research and Opinion Volume 30, 2014 - Issue 10
Submit an article Journal homepage
369
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Management of severe chronic pain with tapentadol prolonged release – long-term data from pain specialists

Volker StrickPain Clinic Rodenkirchen CologneGermanyCorrespondence[email protected]
Pages 2085-2092 | Accepted 24 Jun 2014, Published online: 15 Jul 2014

References

  • Kalso E. The vicious circle in chronic pain management: balancing efficacy and adverse effects. Curr Med Res Opin 2011;27:2069-71
  • Tzschentke TM, De Vry J, Terlinden R, et al. Tapentadol hydrochloride. Analgesic, mu-opioid receptor agonist, noradrenaline reuptake inhibitor. Drugs Future 2006;31:1053-61
  • Afilalo M, Morlion B. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Pain Physician 2013;16:27-40
  • Mercadante S, Porzio G, Ferrera P, et al. Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin 2012;28:1775-9
  • Schwittay A, Schumann C, Litzenburger B, Schwenke K. Tapentadol prolonged release for severe chronic pain: results of a noninterventional study involving general practitioners and internists. J Pain Palliat Care Pharmacother 2013;27:225-34
  • Strohmeier M, Waldmann-Rex S, Schwenke K. Influence of tapentadol retard on functional parameters in patients with severe chronic pain – is there a benefit in daily life? (In German.) MMW Fortschr Med 2013;155:63-71
  • Agbalaka A, Schwenke K, Litzenburger B. Tapentadol prolonged release for the treatment of severe chronic tumor pain in routine clinical practice. (In German.) MMW Fortschr Med 2012;154:123-30
  • Grünenthal GmbH. Fachinformation Palexia retard (German summary of product characteristics). Grünenthal GmbH, November 2012
  • Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J 1968;4:443-53
  • Wild JE, Grond S, Kuperwasser B, et al. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract 2010;10:416-27
  • Frettlöh J, Maier C, Gockel H, Hüppe M. Validation of the German Mainz Pain Staging System in different pain syndromes. (In German.) Schmerz 2003;17:240-51
  • Buynak R, Shapiro DY, Okamoto A, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled phase III study. Expert Opin Pharmacother 2010;11:1787-804
  • Lange B, Kuperwasser B, Okamoto A, et al. Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Adv Ther 2010;27:381-99
  • Merker M, Dinges G, Koch T, et al. Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies. (In German.) Schmerz 2012;26:16-26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.